GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK plc announced the grant of options over Ordinary Shares as part of its Share Save ...

GlaxoSmithKline ( ($GB:GSK) ) has provided an announcement. GSK has announced the purchase of 170,000 of its own ordinary shares as part of its ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 10.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

Deutsche Numis analyst Emmanuel Papadakis reiterated a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of p1,950.00. The company’s shares opened today at p1,537.00.

GlaxoSmithKline (NYSE:GSK) is taking two drug companies to court claiming that their efforts to launch generic versions of enlarged prostate drugs Avodart and Jalyn infringe on GSK patents. Munck ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed last Friday at p1,359.00.

GSK (GSK) came out with quarterly earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.08 per share. This compares to earnings of $1.09 per share a year ago. These figures are ...

GlaxoSmithKline (GSK) will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology, and inflammation (RI&I) as well as oncology, through a collaboration ...

UPDATE: GSK denies it is remotely monitoring its sales reps' laptops. See comment below. Some GlaxoSmithKline (GSK) drug sales reps are freaking out over their employer's move to install Fiberlink 360 ...

GlaxoSmithKline (NYSE:GSK) has been awarded a federal contract that could be worth nearly $95 million if the pharma giant can develop a new antibiotic to combat biothreats such as bubonic plague and ...